Brown, Jacques P <br/><br/>
Antiresorptives: Safety Concerns-Clinical Perspective.  [electronic resource] 

 -  Toxicologic pathology  10 2017 
 - 859-863 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1533-1601 
<br/><br/><label>Standard No.: </label>10.1177/0192623317737066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--pathology<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Remodeling--drug effects<br/>Clinical Trials, Phase III as Topic<br/>Denosumab--adverse effects<br/>Diphosphonates--adverse effects<br/>Female<br/>Femoral Fractures--chemically induced<br/>Humans<br/>Incidence<br/>Observational Studies as Topic<br/>Osteoporosis--drug therapy<br/>Risk Factors